First, 700,000 needles of medicine, one needle and one suite caused a hot discussion among netizens. Because the child at home has a rare spinal muscular atrophy, the child's mother worked hard to make money and finally saved 700 thousand. Just one shot, the child's condition improved, but the drug effect was only three months, and she really had no money to give the child a second shot. I hope that the country can include this medicine in the scope of medical insurance, which has aroused heated discussion among netizens.
Second, spinal muscular atrophy drugs are new drugs. First of all, to be honest, when I saw the news, I thought it was a high-priced drug, and the pharmaceutical factory was black-hearted, but after checking the information, I found that it was not the case. Ma Bao said that in foreign countries, it only costs 205 yuan, because this medicine is included in the social security system and is led by the state. You know, an injection in the United States costs 800,000 yuan, and an injection in China costs 700,000 yuan, which is the price of conscience.
And you must understand that this medicine has been developed abroad for 20 years, and people have paid huge manpower, material resources and financial resources, so it is impossible not to get it back. After all, pharmaceutical companies open their doors to do business, and people are not doing charity. The key point is that this medicine is also imported in China, and there is no pharmaceutical factory in China, so the price is high.
Besides, if you don't want to, you can copy each other's medicine. Isn't this a perfect solution? You are so naive. This new drug has a protection period of 20 years. Simply put, as long as their family can produce this medicine in the past 20 years, it is illegal for other manufacturers to produce it. If you are caught, you need to compensate each other.
Spinal muscular atrophy is a rare disease. In addition to being a new drug, there is another reason that spinal muscular atrophy rarely affects people, thus putting an end to the possibility of mass production of this drug, and it cannot be small profits but quick turnover. So the price can only be expensive, not cheap. This incident tells us that people are simply vulnerable in the face of diseases. Only by working hard and saving money seriously can we resist risks.